Frontier
Copyright ©The Author(s) 2016.
World J Nephrol. Jan 6, 2016; 5(1): 6-19
Published online Jan 6, 2016. doi: 10.5527/wjn.v5.i1.6
Table 4 Supportive therapy of immunoglobulin a nephropathy
Level 1Control blood pressure (sitting systolic BP in the 120 s)
ACE inhibitor or ARB therapy with up-titration of dosage or combination ACE inhibitor and ARB therapy
Level 2Control protein intake
Restrict NaCl intake/institute diuretic therapy
Control each component of the metabolic syndrome
Aldosterone antagonist therapy
Beta-blocker therapy
Smoking cessation
Other measuresAllopurinol therapy
Empiric NaHCO3 therapy, independent of whether metabolic acidosis is present or not
Avoid NSAIDs altogether, or no more than once or twice weekly at most
Avoid prolonged severe hypokalemia
Avoid phosphate cathartics
Ergocalciferol therapy to correct vitamin D deficiency
Control hyperphosphatemia and hyperparathyroidism